Intuitive Surgical Inc
$ 373.71
-0.40%
06 Aug - close price
- Market Cap 134,425,928,000 USD
- Current Price $ 373.71
- High / Low $ 378.64 / 371.68
- Stock P/E 42.20
- Book Value 51.34
- EPS 8.89
- Next Earning Report 2026-10-20
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.10 %
- ROE 0.17 %
- 52 Week High 603.88
- 52 Week Low 328.57
About
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.
Analyst Target Price
$477.25
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-07-16 | 2026-04-21 | 2026-01-22 | 2025-10-21 | 2025-07-22 | 2025-04-22 | 2025-01-23 | 2024-10-17 | 2024-07-18 | 2024-04-18 | 2024-01-23 | 2023-10-19 |
| Reported EPS | 2.37 | 2.5 | 2.53 | 2.4 | 2.19 | 1.81 | 2.21 | 1.84 | 1.78 | 1.5 | 1.6 | 1.46 |
| Estimated EPS | 2.02 | 2.11 | 2.27 | 1.99 | 1.92 | 1.73 | 1.79 | 1.64 | 1.54 | 1.42 | 1.49 | 1.42 |
| Surprise | 0.35 | 0.39 | 0.26 | 0.41 | 0.27 | 0.08 | 0.42 | 0.2 | 0.24 | 0.08 | 0.11 | 0.04 |
| Surprise Percentage | 17.3267% | 18.4834% | 11.4537% | 20.603% | 14.0625% | 4.6243% | 23.4637% | 12.1951% | 15.5844% | 5.6338% | 7.3826% | 2.8169% |
Next Quarterly Earnings
| Sep 2026 | |
|---|---|
| Reported Date | 2026-10-20 |
| Fiscal Date Ending | 2026-09-30 |
| Estimated EPS | 2.63 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ISRG
2026-08-07 09:50:21
This article features Intuitive Surgical CEO Dave Rosa discussing the future of robotic surgery. It highlights the company's role in advancing medical technology and briefly mentions other medical device news and political topics in the healthcare sector.
2026-08-06 19:40:07
Enovis Corporation's shares fell 12.8% after reporting second-quarter earnings, despite revenue and adjusted earnings surpassing Wall Street expectations. The decline was attributed to a weaker full-year earnings per share outlook and a significant contraction in the company's adjusted operating margin, which fell 6.7 percentage points year-on-year to 4.5%. This profitability concern, coupled with broader industry fears about insurance plan changes impacting U.S. procedure growth, led to the negative investor reaction.
2026-08-06 16:30:38
An investment of $1000 in Intuitive Surgical (NASDAQ: ISRG) 20 years ago would now be worth $36,616.17, demonstrating the power of compounded returns. The company has outperformed the market with an annualized return of 19.5% over two decades. Intuitive Surgical currently holds a market capitalization of $133.93 billion.
2026-08-05 21:24:37
Medtronic is advancing AI-assisted surgery with its new Touch Surgery Aide platform and the Hugo robotic surgery system. The platform, which has received FDA clearance for its first AI algorithm (Instrument Exit Point or IEP), aims to improve surgical safety, quality, and efficiency by providing real-time visual assistance to surgeons during procedures. Medtronic envisions a future where AI offers decision support, guidance, and eventually semi-automation in surgery, emphasizing the need for robust computing infrastructure and unbiased, representative data sets.
2026-08-05 20:37:26
Shares of Intuitive Surgical Inc. rallied 1.88% to $375.20 on Wednesday, outperforming the S&P 500 Index which saw a slight decline. The company's stock closed 37.87% below its 52-week high achieved in January. This performance occurred during a mixed trading session where the Dow Jones Industrial Average rose.
2026-08-04 05:07:55
Intuitive Surgical recently amended its bylaws and is facing a Class II recall of over 11,000 da Vinci SP Instrument Arm Drapes. These events highlight the company's approach to shareholder influence and product quality risks. The article examines how the drape recall and governance changes might impact Intuitive Surgical's investment narrative, particularly concerning product quality and potential disruptions to surgical workflows.
